Page 2 - CancerExpertiseFromFinland
P. 2

2

CONTENTS

EXPERTISE FROM FINLAND...............................................4
WHY FINLAND?......................................................................8
FINNISH ECOSYSTEMS AND PLATFORMS.......................10

CANCER IO...................................................................................................12
FINNISH ADVANCED LIGHT MICROSCOPY NODE –
FIALM OF EURO-BIOIMAGING.................................................................14
THE SOUTHERN FINLAND REGIONAL CANCER CENTER –
FICAN SOUTH............................................................................................. 16
FINNISH BIOBANK COOPERATIVE – FINBB......................................... 18
iCAN.............................................................................................................20
INSTITUTE FOR MOLECULAR MEDICINE FINLAND (FIMM)
HILIFE, UNIVERSITY OF HELSINKI....................................................... 22
KUOPIO CENTER FOR GENE AND CELL THERAPY – KCT....................... 24

FINNISH CANCER SOLUTIONS AND TECHNOLOGIES...26
PHARMACEUTICALS, BIOTECH AND RESEARCH...........28

ABOMICS..................................................................................................... 28
AURLIDE.....................................................................................................30
BIOVIAN..................................................................................................... 32
FARON PHARMACEUTICALS.....................................................................34
FINVECTOR................................................................................................. 36
GENEVIA TECHNOLOGIES .......................................................................38
ORION.........................................................................................................40
PHARMATEST SERVICES.......................................................................... 42
TENBORON.................................................................................................. 44
TILT BIOTHERAPEUTICS..........................................................................46
VALO THERAPEUTICS...............................................................................48

DIAGNOSTICS, TESTING AND SCREENING....................50

BIOPSENSE ...............................................................................................50
BLUEPRINT GENETICS............................................................................. 52
FINNADVANCE........................................................................................... 54
LS CANCERDIAG.........................................................................................56
MEGIN.........................................................................................................58
MISVIK BIOLOGY.......................................................................................60
   1   2   3   4   5   6   7